RT Journal Article
SR Electronic
T1 599 Single-agent safety and activities of target-preserving anti-CTLA-4 antibody gotistobart (ONC-392/BNT316) in PD-(L)1 resistant metastatic NSCLC and population PK analysis in patients with solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A682
OP A682
DO 10.1136/jitc-2023-SITC2023.0599
VO 11
IS Suppl 1
A1 He, Kai
A1 McKean, Meredith
A1 Balaraman, Rama
A1 Shah, Satish
A1 Arrowsmith, Edward
A1 Peguero, Julio
A1 Hamm, John
A1 He, Aiwu
A1 Spira, Alexander I
A1 millillo-Naranine, Adriana
A1 Joshi, Rohit
A1 Goldstein, Mark
A1 Carbone, David
A1 Tang, Mei
A1 Hu-Lieskovan, Siwen
A1 Li, Zihai
A1 Chen, Dan
A1 Chou, Hung-Yen
A1 Yang, John
A1 Liu, Yang
A1 Zheng, Pan
A1 Li, Tianhong
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A682.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.